Get started

Stocktowatch

(NSE:OCCL )Oriental Carbon on move up Market Share: # OCCL is the sole manufacturer of Insoluble Sulphur (IS) in the domestic market. Majority of demand for insoluble sulphur is derived from the automotive tyres industry. It enjoy a domestic market share of nearly 55%-60% and around 10% market share in the global market. OCCL has established itself as a preferred first/second supplier to all major tyre manufacturers in global markets Capacity as of FY20: # IS plant spread across 2 units (Dharuhera & SEZ Mundra) of 34,000 metric tonnes per annum. Upcoming Capex # Capacity expansion underway to expand the Insoluble Sulphur capacity by 11,000 MTPA & Sulphuric acid capacity by 42,000 MTPA, spread across two phases at its Dharuhera facility. Total project will cost 216 Cr, funded with a debt equity ratio of 2:1. Phase-I of IS capacity expansion by 5500 MTPA along with Sulphuric acid capacity at an outlay of 156 Cr is underway. Commissioning for the project has been pushed to July2021 from Q3FY21 as envisaged earlier for phase-1. reference: Screener.in
OLong
by Peaceful-Weekend-Investing
Hikal looking to call back glory day on chart.Hikal Ltd. is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Presently, it is operating in the crop protection and pharmaceuticals space. Hikal Ltd CMP is 303.95. The Negative aspect of the company is High Valuation (P.E. = 45.8) and declining annual net profit. The company's Positive aspects are Low debt, zero promoter pledge, FIIs increasing stake, MFs increasing stake, and Improving cash from operations annually. Entry can be taken after closing above 311. Targets in the stock will be 320 and 329. The long-term target in the stock will be 350. Stop loss in the stock should be maintained at Closing below 292. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:HIKALLong
by Happy_Candles_Investment
Page Ind. is on the stage, which has been away from rage. Page Industries Ltd. is the exclusive licensee of JOCKEY International Inc. (USA) for the manufacture, distribution, and marketing of the JOCKEY brand in India, Sri Lanka, Bangladesh, Nepal, Oman, Qatar, Maldives, Bhutan, and the UAE. The Company is the exclusive licensee of Speedo International Ltd. for the manufacture, marketing, and distribution of the Speedo brand in India. Page Industries Ltd CMP is 37852.30. The Negative aspects of the company are High Valuation (P.E. = 82.7), Declining cash from operations annual, FIIs are decreasing stake, Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, MFs are increasing stake, Improving annual net profit. Entry can be taken after closing above 38159. Targets in the stock will be 38809 and 40834. The long-term target in the stock will be 42503 and 43581. Stop loss in the stock should be maintained at Closing below 35893. Page Industries is a portfolio stock and a long term investment idea. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:PAGEINDLong
by Happy_Candles_Investment
NSE : UJJIVANSFB - Train of this small finance bank left NSE:UJJIVANSFB Ujjivan Small Finance Bank Limited is a mass market focused bank in India, catering to financially unserved and underserved segments and committed to building financial inclusion in the country. It started its operations as Ujjivan Financial Services Limited, a Non-Banking Financial Company in 2005 with the mission to provide financial services to the ‘economically active poor’ who were not adequately served by financial institutions. disc: Invested , do you own research .
NSE:UJJIVANSFBLong
by Peaceful-Weekend-Investing
WAPO.N0000Closely monitor mentioned buy zone and strong support zone. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:WAPO.N0000Long
by rukshan2102
NSE:Lupin -trend change on card??? NSE:LUPIN Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others. Disc: Invested, please do you own research
NSE:LUPIN
by Peaceful-Weekend-Investing
V-Gaurd Industries taking a guard for Positive Break outV- guard industries based in Kochi; Kerala is a multi-product company catering to the mass consumption market. The Company is engaged in manufacturing, trading and selling of a wide range of Electronics, Electrical and Consumer Durables. Over the years V-Guard has sold into domestic, industrial and agricultural electronic goods and appliances category. V-Guard operates more than 10 plants across various geographies across India manufacturing multiple categories. V- guard industries Limited CMP is 299.90. The Negative aspects of the company are High Valuation (P.E. = 65), declining annual net profit, FIIs are decreasing stake and promoter Holding decreasing. The positive aspects of the company are Low debt, zero promoter pledge, MFs are increasing stake and improving cash from operations annual. Entry after closing above 304. Targets in the stock will be 312 and 324. Long term targets in the stock will be 335+. Stop loss in the stock should be maintained at closing below 281. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:VGUARDLong
by Happy_Candles_Investment
Trying to make a bottom Dr.Reddy's LabDr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products. Dr Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA).Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy Limited CMP is 5478. The Negative aspects of the company are FIIs are decreasing stake, MFs are decreasing stake and Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, improving annual net profit and improving cash from operations. Entry after closing above 5527. Targets in the stock will be 5642 and 5567. Long term targets in the stock will be 5847 and 5992. Stop loss in the stock should be maintained at closing below 5270. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:DRREDDYLong
by Happy_Candles_Investment